Bachem
Bubendorf
About Bachem
Bachem is an independent, technology-based, public biochemicals company providing full service to the pharma and biotech industry. Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for research purposes. Bachem has more than 40 years of experience in peptide research Excellent know-how in peptide chemistry and organic synthesis (technology leadership) Efficient manufacturing processes (cost leadership) Bachem sets industry standards With headquarters in Bubendorf, Switzerland and affiliates in Europe and the US, Bachem works on a global scale and holds a leading position in the field of peptides.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $50K – $100K
- Total funding: $636.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Apr 2026)
- Website: bachem.com
- Phone: 3105301571
Industries & Categories
Chemical
Social Profiles
Canonical: https://fsome.com/organization/bachem-2221566 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.